Physician profile
Matthew Webb
NPI 1023355237
$1,639.13
in general payments reported to CMS, 2019-2025
21 companies · $348 in 2025
The $348 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $538 · 2022: $299 · 2023: $193 · 2024: $261 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $802.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $527.72 | 2021-2025 | |
| Lilly USA, LLC | $220.04 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Amgen INC. | $134.80 | 2021-2022 | |
| Novo Nordisk INC | $104.27 | 2021-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $83.41 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $79.92 | 2022-2024 | Farxiga |
| Merck Sharp & Dohme LLC | $65.15 | 2021-2024 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Biohaven Pharmaceuticals, INC. | $59.72 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $56.92 | 2022 | |
| Alexion Pharmaceuticals, INC. | $53.20 | 2022 | |
| Exact Sciences Corporation | $34.92 | 2024 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $31.02 | 2022 | |
| Abiomed | $30.65 | 2025 | |
| Astellas Pharma US INC | $29.11 | 2021-2022 | |
| Glaxosmithkline, LLC. | $27.20 | 2021-2023 | Arexvy, Shingrix |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.52 | 2021 | |
| Phathom Pharmaceuticals, INC. | $21.00 | 2024 | Voquezna |
| Novartis Pharmaceuticals Corporation | $19.81 | 2021 | |
| Sunovion Pharmaceuticals INC. | $11.83 | 2021 | |
| Phadia US INC. | $11.52 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.